Therapeutic Services
GMP Manufacturing
We produce clinical trial and commercial material for all major markets, specializing in the production of starting materials and active pharmaceutical ingredients (APIs) for drug substances and vaccines. Our manufacturing capabilities encompass pharmaceuticals produced through chemical or enzymatic methods, as well as biomanufacturing in E. coli and P. pastoris systems.
GMP Plasmid DNA
We have been producing GMP plasmid DNA for starting materials, clinical trials, and commercial applications since 2004. Our proprietary process allows us to scale production seamlessly from gram to kilogram quantities in a single fermentation batch.
GMP Ab fragments
With extensive experience, expert teams, and state-of-the-art equipment, we specialize in GMP manufacturing of antibody fragment formats including VHH, scFv, Fab, diabody, and bispecific tandem scFv using E. coli and P. pastoris.
GMP Recombinant Proteins
With decades of expertise in GMP manufacturing, we specialize in developing, optimizing processes, and manufacturing recombinant proteins for clinical trial and commercial uses at both small and large scales.
GMP Protein Conjugates
We provide expertise in process development and GMP manufacturing of chemically modified recombinant proteins for human clinical trials and commercial applications.
GMP mRNA
We specialize in the production of messenger RNA (mRNA) from 0.5 to 50 g for use as Active Pharmaceutical Ingredients (APIs) in preclinical Tox studies and Human Clinical Trials. Our expertise ensures compliance with rigorous quality standards, supporting the development of mRNA-based therapies and vaccines.
Preclinical & Therapeutic Oligonucleotides
As experts in therapeutic oligonucleotides, we offer comprehensive, tailored solutions for developing, manufacturing, and testing preclinical and clinical oligonucleotides. We ensure each oligonucleotide is synthesized to meet your specifications.
GMP Peptide Manufacturing
We specialize in manufacturing GMP-grade peptides for Clinical uses, Emergency IND (EIND) use, API precursors, and starting materials. Our commitment to quality ensures these peptides meet rigorous standards, supporting their use in advancing therapeutic solutions across pharmaceutical research and development initiatives.